| Aug 24, 2009
| 3:32 PM
WASHINGTON -- The Food and Drug Administration is investigating reports of liver damage in patients taking alli, the only nonprescription weight loss drug approved by the agency.
Regulators said Monday they have received more than 30 reports of liver...
| Oct 19, 2009
Rushed into production? Not really.
Full of substances that do harm? Hardly, and especially not compared with the dangers of the H1N1 flu virus.
That is the retort of researchers, scientists, federal health authorities and others familiar...
| Feb 16, 2009
It's one instance where quitting isn't the easy way out.
FOR THE RECORD:
Zyban: In Monday's Health section, an article on quitting smoking said that the smoking-cessation medication Zyban might act by blocking the brain chemicals...
| Jan 29, 2009
I'm grateful for the opportunity to be here today and present my closing argument and my chance to talk to you and talk to the people of Illinois and talk to anybody else who is listening.
In the last couple of days I've had a chance to be able to go out...
| Jul 13, 2010
| 8:26 AM
GlaxoSmithKline agreed to pay about $460 million to resolve a majority of lawsuits alleging the company's Avandia diabetes drug can cause heart attacks and strokes, people familiar with the accords said.
Glaxo, the U.K.'s biggest drugmaker, agreed to...
| Jun 30, 2010
| 2:11 PM
The arthritis pill Vioxx was withdrawn but menopause hormones were not, even though both were tied to heart risks. A multiple sclerosis medicine was pulled and later allowed back on.
So, when is a drug too risky to stay on the market?
| Jun 29, 2010
The diabetes drug Avandia, once the world's top-selling diabetes medication, took two more hits Monday with one new study linking it to an increased risk of heart attacks and a separate study linking it to an increased risk of heart failure and stroke....
| Jul 14, 2010
| 12:54 PM
U.S. health advisers said GlaxoSmithKline Plc's GSK.L diabetes drug Avandia should be allowed to stay on the market in some form, easing a threat of further litigation that could have followed a ban.
The 33-member panel of outside experts convened by the...
| Jul 15, 2010
Faced with conflicting and less-than-conclusive scientific evidence, a Food and Drug Administration advisory panel recommended Wednesday that the controversial diabetes drug Avandia remain on the market — but with tighter supervision and increased...
| Aug 13, 2010
Men who took erectile dysfunction drugs such as Viagra were more likely to become infected with sexually transmitted diseases, including AIDS, U.S. researchers have reported.
This infection rate was higher even in the year before the men got their...
| Feb 18, 2010
| 11:19 AM
WASHINGTON (AP) - GlaxoSmithKline said Thursday it will remove zinc from its denture cream, following reports that excessive use over many years can cause neurological damage and blood problems in consumers.
The British manufacturer will cease...